CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 193 of 859
Non-Antibody Products
Page 193 of 859
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| C24 (2'(R)-hydroxy) Ceramide (d18:1/24:0) | A synthetic ceramide; has been used in the preparation of synthetic lipid… | 5 mg | 22527-5 | More Info |
| C24 (2'(R)-hydroxy) dihydro Ceramide (d18:0/24:0) | A hydroxylated dihydro ceramide | 1 mg | 28935-1 | More Info |
| C24 (2'(R)-hydroxy) Phytoceramide (t18:0/24:0) | A naturally occurring sphingolipid; inhibits LPS-induced NO production in… | 1 mg | 28933-1 | More Info |
| Cridanimod (sodium salt) | An inducer of type I interferon production; induces IRF3 phosphorylation,… | 1 mg | 27884-1 | More Info |
| Cridanimod (sodium salt) | An inducer of type I interferon production; induces IRF3 phosphorylation,… | 10 mg | 27884-10 | More Info |
| Cridanimod (sodium salt) | An inducer of type I interferon production; induces IRF3 phosphorylation,… | 5 mg | 27884-5 | More Info |
| cRIPGBM | An active metabolite of RIPGBM; formed from RIPGBM selectively in GBM1 CSC… | 10 mg | 38115-10 | More Info |
| cRIPGBM | An active metabolite of RIPGBM; formed from RIPGBM selectively in GBM1 CSC… | 25 mg | 38115-25 | More Info |
| cRIPGBM | An active metabolite of RIPGBM; formed from RIPGBM selectively in GBM1 CSC… | 5 mg | 38115-5 | More Info |
| CRL-40,941 | An analytical reference standard categorized as a nootropic; intended for… | 1 mg | 19138-1 | More Info |
| CRL-40,941 | An analytical reference standard categorized as a nootropic; intended for… | 5 mg | 19138-5 | More Info |
| Crocin/Gardenia Extract | A Gardenia extract that contains crocin I, II, and III, and crocetin, amon… | 1 g | 26337-1 | More Info |
| Crocin/Gardenia Extract | A Gardenia extract that contains crocin I, II, and III, and crocetin, amon… | 5 g | 26337-5 | More Info |
| Crocin/Gardenia Extract | A Gardenia extract that contains crocin I, II, and III, and crocetin, amon… | 500 mg | 26337-500 | More Info |
| Cromolyn (sodium salt hydrate) | A chromone complex that acts as a mast cell stabilizer to prevent the rele… | 1 g | 21379-1 | More Info |
| Cromolyn (sodium salt hydrate) | A chromone complex that acts as a mast cell stabilizer to prevent the rele… | 10 g | 21379-10 | More Info |
| Cromolyn (sodium salt hydrate) | A chromone complex that acts as a mast cell stabilizer to prevent the rele… | 25 g | 21379-25 | More Info |
| Cromolyn (sodium salt hydrate) | A chromone complex that acts as a mast cell stabilizer to prevent the rele… | 5 g | 21379-5 | More Info |
| Cropropamide | A component of prethcamide; increases locomotor activity in rats at 33.69… | 10 mg | 30888-10 | More Info |
| Cropropamide | A component of prethcamide; increases locomotor activity in rats at 33.69… | 25 mg | 30888-25 | More Info |
| Cropropamide | A component of prethcamide; increases locomotor activity in rats at 33.69… | 5 mg | 30888-5 | More Info |
| Crosstide (trifluoroacetate salt) | A peptide substrate for Akt; corresponds to the amino acid sequence of GSK… | 1 mg | 36889-1 | More Info |
| Crosstide (trifluoroacetate salt) | A peptide substrate for Akt; corresponds to the amino acid sequence of GSK… | 10 mg | 36889-10 | More Info |
| Crosstide (trifluoroacetate salt) | A peptide substrate for Akt; corresponds to the amino acid sequence of GSK… | 5 mg | 36889-5 | More Info |
| Crotamiton | An ectoparasiticide and antipruritic agent; blocks mouse TRPV4 channel exp… | 100 mg | 23943-100 | More Info |
| Crotonoside | A guanosine analog with diverse biological activities; cytotoxic to P338,… | 1 mg | 28219-1 | More Info |
| Crotonoside | A guanosine analog with diverse biological activities; cytotoxic to P338,… | 10 mg | 28219-10 | More Info |
| Crotonoside | A guanosine analog with diverse biological activities; cytotoxic to P338,… | 25 mg | 28219-25 | More Info |
| Crotonoside | A guanosine analog with diverse biological activities; cytotoxic to P338,… | 5 mg | 28219-5 | More Info |
| Crotonyl fentanyl-d5 | An internal standard for the quantification of crotonyl fentanyl by GC- or… | 1 mg | 25132-1 | More Info |
| Crotonyl fentanyl-d5 | An internal standard for the quantification of crotonyl fentanyl by GC- or… | 500 µg | 25132-500 | More Info |
| Crotonyl fentanyl (exempt preparation) | An analytical reference material categorized as an opioid; induces general… | 100 µg | 39889-100 | More Info |
| CRT0036521 | An inhibitor of prostaglandin F synthase / AKR1C3 (IC50 = 0.013 µM);… | 100 mg | 36600-100 | More Info |
| CRT0036521 | An inhibitor of prostaglandin F synthase / AKR1C3 (IC50 = 0.013 µM);… | 250 mg | 36600-250 | More Info |
| CRT0036521 | An inhibitor of prostaglandin F synthase / AKR1C3 (IC50 = 0.013 µM);… | 50 mg | 36600-50 | More Info |
| CRT0036521 | An inhibitor of prostaglandin F synthase / AKR1C3 (IC50 = 0.013 µM);… | 500 mg | 36600-500 | More Info |
| CRT0066854 | A PKCι and PKCζ inhibitor (IC50s = 132 and 639 nM, respectively)… | 1 mg | 28463-1 | More Info |
| CRT0066854 | A PKCι and PKCζ inhibitor (IC50s = 132 and 639 nM, respectively)… | 10 mg | 28463-10 | More Info |
| CRT0066854 | A PKCι and PKCζ inhibitor (IC50s = 132 and 639 nM, respectively)… | 5 mg | 28463-5 | More Info |
| CRT0273750 | An ENPP2 inhibitor (IC50 = 1 nM); prevents lysophosphatidylcholine hydroly… | 1 mg | 20904-1 | More Info |
| CRT0273750 | An ENPP2 inhibitor (IC50 = 1 nM); prevents lysophosphatidylcholine hydroly… | 10 mg | 20904-10 | More Info |
| CRT0273750 | An ENPP2 inhibitor (IC50 = 1 nM); prevents lysophosphatidylcholine hydroly… | 25 mg | 20904-25 | More Info |
| CRT0273750 | An ENPP2 inhibitor (IC50 = 1 nM); prevents lysophosphatidylcholine hydroly… | 5 mg | 20904-5 | More Info |
| CRT5 | A pyrazine benzamide that prevents activation of all three isoforms of PKD… | 1 mg | 18532-1 | More Info |
| CRT5 | A pyrazine benzamide that prevents activation of all three isoforms of PKD… | 10 mg | 18532-10 | More Info |
| CRT5 | A pyrazine benzamide that prevents activation of all three isoforms of PKD… | 25 mg | 18532-25 | More Info |
| CRT5 | A pyrazine benzamide that prevents activation of all three isoforms of PKD… | 5 mg | 18532-5 | More Info |
| CRTH2/DP2 Receptor (C-Term) Blocking Peptide | Peptide Sequence: CRTH2 / DP2 protein amino acids 378-395 · To be u… | 1 ea | 10007003-1 | More Info |
| CRTH2/DP2 Receptor (N-Term) Blocking Peptide | Peptide Sequence: CRTH2 / DP2 protein amino acids 2-21 · To be used… | 1 ea | 10004884-200 | More Info |
| CRT0066101 (hydrochloride) | A pan inhibitor PKD (IC50s = 1, 2.5, and 2 nM for PKD1, PKD2, and PKD3, re… | 1 mg | 15337-1 | More Info |
| CRT0066101 (hydrochloride) | A pan inhibitor PKD (IC50s = 1, 2.5, and 2 nM for PKD1, PKD2, and PKD3, re… | 10 mg | 15337-10 | More Info |
| CRT0066101 (hydrochloride) | A pan inhibitor PKD (IC50s = 1, 2.5, and 2 nM for PKD1, PKD2, and PKD3, re… | 5 mg | 15337-5 | More Info |
| Cryogenine | An alkaloid with anti-inflammatory activity; inhibits prostaglandin synthe… | 1 mg | 25287-1 | More Info |
| Cryogenine | An alkaloid with anti-inflammatory activity; inhibits prostaglandin synthe… | 10 mg | 25287-10 | More Info |
| Cryogenine | An alkaloid with anti-inflammatory activity; inhibits prostaglandin synthe… | 5 mg | 25287-5 | More Info |
| Cryptochlorogenic Acid | A phenolic acid with diverse biological activities; inhibits RLAR in vitro… | 10 mg | 25098-10 | More Info |
| Cryptochlorogenic Acid | A phenolic acid with diverse biological activities; inhibits RLAR in vitro… | 100 mg | 25098-100 | More Info |
| Cryptochlorogenic Acid | A phenolic acid with diverse biological activities; inhibits RLAR in vitro… | 50 mg | 25098-50 | More Info |
| (-)-Cryptopleurine | An alkaloid; inhibits the growth of human A375, A431, A549, MES-SA, and MC… | 1 mg | 31642-1 | More Info |
| (-)-Cryptopleurine | An alkaloid; inhibits the growth of human A375, A431, A549, MES-SA, and MC… | 5 mg | 31642-5 | More Info |
| Cryptotanshinone | A natural quinoid diterpene that, at 10-20 µM, stimulates AMPK in C2… | 10 mg | 16987-10 | More Info |
| Cryptotanshinone | A natural quinoid diterpene that, at 10-20 µM, stimulates AMPK in C2… | 25 mg | 16987-25 | More Info |
| Cryptotanshinone | A natural quinoid diterpene that, at 10-20 µM, stimulates AMPK in C2… | 5 mg | 16987-5 | More Info |
| Cryptotanshinone | A natural quinoid diterpene that, at 10-20 µM, stimulates AMPK in C2… | 50 mg | 16987-50 | More Info |
| CS2164 | A multi-kinase inhibitor; inhibits VEGFR1, -2, and -3 (IC50s = 8, 7, and 9… | 10 mg | 38766-10 | More Info |
| CS2164 | A multi-kinase inhibitor; inhibits VEGFR1, -2, and -3 (IC50s = 8, 7, and 9… | 25 mg | 38766-25 | More Info |
| CS2164 | A multi-kinase inhibitor; inhibits VEGFR1, -2, and -3 (IC50s = 8, 7, and 9… | 5 mg | 38766-5 | More Info |
| C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) | A synthetic ceramide; has no effect on C6 glioma cell viability at concent… | 1 mg | 22516-1 | More Info |
| C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) | A synthetic ceramide; has no effect on C6 glioma cell viability at concent… | 10 mg | 22516-10 | More Info |
| C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) | A synthetic ceramide; has no effect on C6 glioma cell viability at concent… | 25 mg | 22516-25 | More Info |
| C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) | A synthetic ceramide; has no effect on C6 glioma cell viability at concent… | 5 mg | 22516-5 | More Info |
| C24 (2'(S)-hydroxy) Ceramide (d18:1/24:0) | A ceramide; has been found in D. lenticellatum | 1 mg | 22526-1 | More Info |
| C24 (2'(S)-hydroxy) Ceramide (d18:1/24:0) | A ceramide; has been found in D. lenticellatum | 5 mg | 22526-5 | More Info |
| C24 (2'(S)-hydroxy) dihydro Ceramide (d18:0/24:0) | A hydroxylated dihydro ceramide | 1 mg | 28936-1 | More Info |
| C24 (2'(S)-hydroxy) Phytoceramide (t18:0/24:0) | A sphingolipid | 1 mg | 28934-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile